Weatherstone Capital Management’s AbbVie ABBV Stock Holding History

Weatherstone Capital Management’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-3,745	Closed	-$235K	–	80
2016 Q4	$235K	Buy	+3,745	New	+$229K	0.15%	81
2016 Q3	–	Sell	-3,745	Closed	-$232K	–	82
2016 Q2	$232K	Hold	3,745	–	–	0.2%	77
2016 Q1	$214K	Sell	3,745 -1,633	-30%	-$91K	0.15%	76
2015 Q4	$319K	Sell	5,378 -11	-0.2%	-$634	0.36%	51
2015 Q3	$293K	Sell	5,389 -427	-7%	-$27.8K	0.27%	41
2015 Q2	$391K	Buy	5,816 +167	+3%	+$10.9K	0.35%	43
2015 Q1	$356K	Buy	5,649 +915	+19%	+$55.3K	0.22%	53
2014 Q4	$310K	Buy	4,734 +979	+26%	+$61.7K	0.18%	50
2014 Q3	$220K	Buy	+3,755	New	+$208K	0.11%	59

Other funds holding ABBV

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Weatherstone Capital Management's ABBV Position: Q1 2017 in Review

Weatherstone Capital Management sold out of AbbVie (ABBV) in Q1 2017, closing a stake of 3,745 shares — an estimated $235K sold.

Weatherstone Capital Management first reported a position in ABBV in Q3 2014 and held it in 9 quarters. The position peaked at $391K in Q2 2015. 1,727 funds tracked by Wall St. Rank hold ABBV as of Q1 2017.

Weatherstone Capital Management reported no remaining AbbVie position as of Q1 2017 after selling out during the quarter.
Weatherstone Capital Management sold 3,745 AbbVie shares in Q1 2017, an estimated $235K.
Weatherstone Capital Management first reported a position in AbbVie in Q3 2014 and held it in 9 quarters.
Weatherstone Capital Management's AbbVie position peaked at $391K in Q2 2015.
1,727 funds tracked by Wall St. Rank held AbbVie as of Q1 2017.

Based on Weatherstone Capital Management's 13F filing for Q1 2017, filed 11 May 2017.